Related Experiment Videos
Efficacy and safety of ceftriaxone in serious pediatric infections
Antimicrobial Agents and Chemotherapy
|November 1, 1983
Abstract:
Thirty-four patients aged 1 month to 19 years were treated with ceftriaxone for suspected bacterial infections. Bacterial pathogens were isolated from 25 children. The overall bacterial cure rate was 88%, with an overall clinical response rate of 96%. No side effects requiring cessation of therapy were observed. Ceftriaxone proved to be safe and effective in the treatment of serious infections in children.
Insights
Ceftriaxone effectively treated serious bacterial infections in children, showing high cure (88%) and response (96%) rates. This antibiotic was found safe and well-tolerated in pediatric patients.
Area of Science:
- Pediatric Infectious Diseases
- Bacteriology
- Clinical Pharmacology
Background:
- Bacterial infections pose significant health risks in pediatric populations.
- Effective and safe antimicrobial agents are crucial for treating serious infections in children.
Purpose of the Study:
- To evaluate the efficacy and safety of ceftriaxone in treating suspected bacterial infections in pediatric patients.
- To determine bacterial cure and clinical response rates associated with ceftriaxone therapy.
Main Methods:
- A cohort of 34 pediatric patients (1 month to 19 years) with suspected bacterial infections received ceftriaxone.
- Bacterial pathogens were identified in 25 of the patients.
- Treatment outcomes including bacterial cure and clinical response were assessed.
Main Results:
- An 88% bacterial cure rate was observed.
- A 96% overall clinical response rate was achieved.
- No adverse events necessitated the discontinuation of ceftriaxone therapy.
Conclusions:
- Ceftriaxone demonstrated significant safety and efficacy in treating serious bacterial infections in children.
- The antibiotic is a viable therapeutic option for pediatric bacterial infections.